Latest Insider Transactions at Cardinal Health Inc (CAH)
This section provides a real-time view of insider transactions for Cardinal Health Inc (CAH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CARDINAL HEALTH INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CARDINAL HEALTH INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2022
|
Victor L. Crawford CEO, Pharmaceutical Segment |
BUY
Grant, award, or other acquisition
|
Direct |
17,150
+11.22%
|
-
|
|
Aug 15
2022
|
Patricia M English Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,313
-12.73%
|
$90,597
$69.32 P/Share
|
|
Aug 15
2022
|
Patricia M English Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,144
+17.21%
|
-
|
|
Aug 15
2022
|
Jessica L Mayer Chief Legal/Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,212
-6.35%
|
$1,256,628
$69.32 P/Share
|
|
Aug 15
2022
|
Jessica L Mayer Chief Legal/Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
442
+0.35%
|
$17,238
$39.81 P/Share
|
|
Aug 15
2022
|
Jessica L Mayer Chief Legal/Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,721
+9.86%
|
-
|
|
Aug 09
2022
|
Stephen M Mason CEO, GMPD Segment |
BUY
Grant, award, or other acquisition
|
Direct |
29,893
+23.23%
|
-
|
|
Aug 09
2022
|
Brian S Rice Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,286
+21.79%
|
-
|
|
Aug 09
2022
|
Jessica L Mayer Chief Legal/Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,250
+15.37%
|
-
|
|
Aug 09
2022
|
Michael C Kaufmann CEO |
BUY
Grant, award, or other acquisition
|
Direct |
132,857
+16.49%
|
-
|
|
Aug 09
2022
|
Ola M Snow Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,607
+23.66%
|
-
|
|
Aug 09
2022
|
Jason M. Hollar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,999
+21.08%
|
-
|
|
Aug 09
2022
|
Michele Holcomb EVP - Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
13,286
+19.69%
|
-
|
|
Aug 09
2022
|
Victor L. Crawford CEO, Pharmaceutical Segment |
BUY
Grant, award, or other acquisition
|
Direct |
36,536
+23.57%
|
-
|
|
Jun 28
2022
|
Michael C Kaufmann CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,523
-1.73%
|
$514,242
$54.86 P/Share
|
|
May 15
2022
|
Jason M. Hollar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,392
-6.11%
|
$186,560
$55.61 P/Share
|
|
Mar 15
2022
|
Jessica L Mayer Chief Legal/Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,332
-1.25%
|
$69,264
$52.61 P/Share
|
|
Feb 15
2022
|
Brian S Rice Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,960
-5.39%
|
$101,920
$52.29 P/Share
|
|
Jan 18
2022
|
Ola M Snow Chief Human Resources Officer |
BUY
Open market or private purchase
|
Direct |
112
+0.37%
|
$5,936
$53.12 P/Share
|
|
Dec 01
2021
|
Michael C Kaufmann CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,798
-0.51%
|
$128,708
$46.23 P/Share
|
|
Nov 18
2021
|
Ola M Snow Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
10,000
-21.29%
|
$490,000
$49.17 P/Share
|
|
Nov 15
2021
|
Victor L. Crawford CEO, Pharmaceutical Segment |
SELL
Payment of exercise price or tax liability
|
Direct |
4,391
-5.08%
|
$223,941
$51.44 P/Share
|
|
Nov 15
2021
|
Jessica L Mayer Chief Legal/Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,681
+24.63%
|
-
|
|
Nov 11
2021
|
Sheri H. Edison Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,709
+32.29%
|
-
|
|
Nov 11
2021
|
David C Evans Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,709
+30.88%
|
-
|
|
Nov 11
2021
|
John H Weiland Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,709
+24.98%
|
-
|
|
Nov 11
2021
|
Patricia Hemingway Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,709
+12.83%
|
-
|
|
Nov 11
2021
|
Carrie Smith Cox Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,709
+8.62%
|
-
|
|
Nov 11
2021
|
Bruce Downey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,709
+6.7%
|
-
|
|
Nov 11
2021
|
Akhil Johri Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,709
+19.01%
|
-
|
|
Nov 11
2021
|
Dean A Scarborough Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,709
+24.98%
|
-
|
|
Nov 11
2021
|
Gregory B Kenny Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,215
+10.56%
|
-
|
|
Nov 11
2021
|
Nancy Killefer Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,709
+15.29%
|
-
|
|
Oct 15
2021
|
Ola M Snow Chief Human Resources Officer |
BUY
Open market or private purchase
|
Direct |
212
+0.7%
|
$10,176
$48.88 P/Share
|
|
Oct 15
2021
|
Ola M Snow Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
726
-1.52%
|
$34,848
$48.63 P/Share
|
|
Aug 15
2021
|
Victor L. Crawford CEO, Pharmaceutical Segment |
SELL
Payment of exercise price or tax liability
|
Direct |
19,991
-18.8%
|
$1,019,541
$51.7 P/Share
|
|
Aug 15
2021
|
Victor L. Crawford CEO, Pharmaceutical Segment |
BUY
Grant, award, or other acquisition
|
Direct |
21,277
+16.67%
|
-
|
|
Aug 15
2021
|
Michael C Kaufmann CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
77,365
-12.28%
|
$3,945,615
$51.7 P/Share
|
|
Aug 15
2021
|
Michael C Kaufmann CEO |
BUY
Grant, award, or other acquisition
|
Direct |
85,106
+11.9%
|
-
|
|
Aug 15
2021
|
Jason M. Hollar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,785
-4.78%
|
$142,035
$51.7 P/Share
|
|
Aug 15
2021
|
Jason M. Hollar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,277
+26.74%
|
-
|
|
Aug 15
2021
|
Brian S Rice Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,362
-14.89%
|
$324,462
$51.7 P/Share
|
|
Aug 15
2021
|
Brian S Rice Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,511
+16.61%
|
-
|
|
Aug 15
2021
|
Jessica L Mayer Chief Legal/Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,884
-16.2%
|
$708,084
$51.7 P/Share
|
|
Aug 15
2021
|
Jessica L Mayer Chief Legal/Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,342
+18.41%
|
-
|
|
Aug 15
2021
|
Patricia M English Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
817
-9.09%
|
$41,667
$51.7 P/Share
|
|
Aug 15
2021
|
Patricia M English Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+24.4%
|
-
|
|
Aug 15
2021
|
Ola M Snow Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,663
-10.61%
|
$288,813
$51.7 P/Share
|
|
Aug 15
2021
|
Ola M Snow Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,540
+20.24%
|
-
|
|
Aug 15
2021
|
Stephen M Mason CEO, GMPD Segment |
SELL
Payment of exercise price or tax liability
|
Direct |
10,395
-13.11%
|
$530,145
$51.7 P/Share
|